Home688266 • SHA
add
Suzhou Zelgen Biopharmaceuticals Co Ltd
Previous close
¥97.40
Day range
¥96.47 - ¥100.50
Year range
¥49.00 - ¥110.93
Market cap
25.78B CNY
Avg Volume
3.74M
P/E ratio
-
Dividend yield
-
Primary exchange
SHA
Market news
Financials
Income Statement
Revenue
Net income
(CNY) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | 167.64M | 54.87% |
Operating expense | 188.41M | 20.26% |
Net income | -28.26M | 28.45% |
Net profit margin | -16.86 | 53.80% |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | 3.31% | — |
Balance Sheet
Total assets
Total liabilities
(CNY) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 2.14B | -11.53% |
Total assets | 2.92B | -6.02% |
Total liabilities | 1.69B | 12.64% |
Total equity | 1.22B | — |
Shares outstanding | 264.71M | — |
Price to book | 21.04 | — |
Return on assets | — | — |
Return on capital | -4.52% | — |
Cash Flow
Net change in cash
(CNY) | Mar 2025info | Y/Y change |
---|---|---|
Net income | -28.26M | 28.45% |
Cash from operations | -6.25M | -107.02% |
Cash from investing | -26.63M | 91.57% |
Cash from financing | -31.80M | -133.61% |
Net change in cash | -64.69M | 51.09% |
Free cash flow | — | — |
About
Founded
Mar 18, 2009
Website
Employees
910